DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Apolo AB, Infante JR, Balmanoukian A. et al.
Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study.
J Clin Oncol 2017;
35: 2117-2124
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.